关于NQO2的多态和药物基因组学:过去和未来
Elzbieta Janda1, Jean A Boutin2, Carlo De Lorenzo1
1Laboratory of Cellular and Molecular Toxicology, Department of Health Science, University "Magna Græcia" of Catanzaro, 88100 Catanzaro, Italy.
Genes
|January 23, 2024
概括
在NQO2基因的遗传变异影响癌症风险和药物反应. NQO2基因变异也与神经退行性疾病如帕金森病和阿尔茨海默病有关.
科学领域:
- 生物化学 生化学
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 类酶N-ribosyldihydronicotinamide (NRH):类氧化降解酶2 (NQO2) 参与类代谢,影响药物排毒,并可能影响癌症和神经退行.
- 在各种化合物的新陈代谢中,包括抗瘤药物中,NQO2既具有毒性作用,也具有排毒作用.
- NQO2活性可以通过像黄类药物这样的抑制剂来调节,并在细胞过程中发挥作用,例如氧化应激,炎症和自.
研究的目的:
- 系统地审查NQO2基因变异作为退行性疾病和药物不良影响的风险因素的文献.
- 调查NQO2多态性与对癌症和神经退行性疾病的易感性之间的联系.
- 探索NQO2变异对药物反应和毒性的个体间变异性的影响.
主要方法:
- 对调查NQO2基因变异的研究进行系统文献综述.
- 分析NQO2多态 (包括插入,删除和SNP) 与疾病风险或药物反应之间的关联.
- 检查NQO2变体在促进和编码区域的功能影响.
主要成果:
- 低形态的NQO2的29 bp I等位基因与对乳腺癌和其他固体癌症的敏感性增加以及化疗反应的变异性有关.
- 过度形态的NQO2多态已经与帕金森病和阿尔茨海默病的风险增加有关.
- NQO2促进体变体 (I和D) 和其他多态体可能会影响认知衰退,酒以及中枢神经系统药物的毒性.
结论:
- NQO2基因变异代表了各种退行性疾病的重大风险因素,并可能导致不良药物反应.
- 了解NQO2多态性对于个性化医学至关重要,特别是在癌症治疗和神经系统疾病管理中.
- 需要进一步的研究,以充分阐明NQO2变体在健康和疾病中的复杂作用.
相关概念视频
Nonlinear Pharmacokinetics: Role of Transporters
51
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Polymorphisms occurring in drug transporters can alter...
51
Single Nucleotide Polymorphisms-SNPs
15.1K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.1K
Analysis of Population Pharmacokinetic Data
263
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
263
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
148
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
148
Nonlinear Pharmacokinetics: Causes of Nonlinearity
191
Nonlinearity in drug pharmacokinetics is caused by various factors influencing how a drug is absorbed, distributed, metabolized, and excreted. Understanding these nonlinear processes is crucial for predicting drug behavior in the body and optimizing drug dosing regimens.
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
191
Drug Distribution as One-Compartment Model and Elimination by Nonlinear Pharmacokinetics: Overview
71
Drug administration can occur through various routes, each of which may result in a different process of elimination. This process is often mixed with nonlinear and linear processes. It's important to understand that a single drug can be metabolized into different metabolites through parallel processes.
For instance, consider the metabolism of sodium salicylate. This compound is metabolized into two distinct substances: a glucuronide and a glycine conjugate. The rate of conjugation depends...
For instance, consider the metabolism of sodium salicylate. This compound is metabolized into two distinct substances: a glucuronide and a glycine conjugate. The rate of conjugation depends...
71


